Source:Journal of Allergy and Clinical Immunology
Author(s): Melanie C. Dispenza, Jacqueline A. Pongracic, Anne Marie Singh, Bruce S. Bochner
Teaser
Two doses of ibrutinib significantly reduced skin prick test area and anti-IgE-induced basophil activation responses in peanut and tree nut allergic adults. Ibrutinib or other BTK inhibitors could potentially be used to prevent anaphylaxis.http://ift.tt/2ErcNp5
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου